ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 271674 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 271674; 2) Community: the network communities that were significantly associated with the response to NSC 271674; 3) Molecule: the relationships between components within communities and NSC 271674; 4) MDR: the compounds that were significantly associated with the NSC 271674.

NSC Compound Enrichment Correlation
NSC 695788 N(sup .alpha.)-[4-[(2,4-Diamino-5-methylpyrido[2,3-d] pyrimidin-6-yl)methyl]amino]benzoyl-n(sup .delta.)-hemiphthaloyl-L-ornithine 0.0257805259050655 0.56037889
NSC 716040 Null 0.0257805259050655 0.38660737
NSC 726367 Null 0.0257805259050655 0.019833847
NSC 748873 Null 0.0257805259050655 0.34991839
NSC 749028 Null 0.0257805259050655 0.087757504
NSC 753577 N1-(6-fluoro-1,3-benzothiazol-2-yl)-2-2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxyacetamide 0.0257805259050655 0.070961593
NSC 755264 Null 0.0257805259050655 0.47525048
NSC 755267 Null 0.0257805259050655 0.46792585
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.0257805259050655 0.36969973
NSC 92954 Card-20(22)-enolide, 3-(acetyloxy)-5,14-dihydroxy-19-oxo-, (3.beta.,5.beta.)- (9CI) 0.0257805259050655 0.34311976
Total:112  Current:70    [First] [Prev] [Next] [Last]